GSE95077 1 V 2 AMILORIDE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE95077 1 V 2 AMILORIDE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE95077 1 V 2 AMILORIDE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE95077 1 V 2 AMILORIDE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE95077 1 V 2 AMILORIDE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

ribosomal protein S18

Gene

NBPF member 8

Gene

uncharaterized LOC112694756

Gene

protein phosphatase 2 regulatory subunit B''beta

Gene

P2Y receptor family member 8

Gene

zinc finger protein 883

Gene

ADAM metallopeptidase with thrombospondin type 1 motif 17

Gene

CaM kinase like vesicle associated

Gene

DiGeorge syndrome critical region gene 6 like

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    ribosomal protein S18



  • Gene

    uncharaterized LOC112694756


  • Gene

    protein phosphatase 2 regulatory subunit B''beta


  • Gene

    P2Y receptor family member 8


  • Gene

    zinc finger protein 883


  • Gene

    ADAM metallopeptidase with thrombospondin type 1 motif 17


  • Gene

    CaM kinase like vesicle associated


  • Gene

    DiGeorge syndrome critical region gene 6 like

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.